+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

eClinical Solutions Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337404
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As clinical trial processes become more complex, life sciences organizations are navigating intersecting regulatory, technological, and patient engagement pressures. Senior leaders are increasingly examining how interoperable eClinical solutions and integrated service models shape compliance and sustain competitive edge in a changing ecosystem.

Market Snapshot: eClinical Solutions Market Size and Growth

The eClinical Solutions Market is experiencing substantial expansion, with global revenues projected to rise from USD 11.69 billion in 2025 to USD 13.25 billion in 2026. Key drivers fueling this growth include advancements in digital trial technology, strong demand for integrated software and service ecosystems, and greater adoption of cloud-centric platforms. The result is a compound annual growth rate of 14.59%, positioning the market to reach an estimated value of USD 30.33 billion by 2032. Senior decision-makers recognize that digitalization is reshaping the way clinical trials are designed, executed, and governed worldwide.

Scope & Segmentation

This analysis delivers a comprehensive view of the evolving clinical trial technology landscape, offering detailed segmentation by core business and technology dimensions:

  • Component Types: Includes evaluations of consulting, implementation, support and maintenance services, and key software platforms such as clinical trial management systems, e-data capture solutions, electronic clinical outcome assessments, and e-trial master file systems.
  • Deployment Models: Reviews cloud-native, hybrid cloud, public, private, and on-premise approaches, focusing on unique considerations around security, scalability, and compliance for each.
  • End User Segments: Analyzes procurement strategies and needs across pharmaceutical and biotechnology companies, academic research institutions, contract research organizations, and clinical settings like hospitals and clinics.
  • Trial Phases: Covers solution application and priorities from early-phase studies to post-approval evidence generation, with emphasis on operational requirements supporting each stage.
  • Therapeutic Areas: Provides targeted insights into technology requirements and workflows for cardiology, neurology, oncology, and other high-complexity specialty trials.
  • Key Regions: Investigates market dynamics and regulatory frameworks across Americas, Europe, Middle East & Africa, and Asia-Pacific, taking into account local operational challenges and data privacy regimes.
  • Technologies Profiled: Features eCOA, eTMF, EDC platforms, clinical trial management systems, advances in data interoperability, and decentralized trial enablement frameworks.

Key Takeaways for Senior Decision-Makers

  • Cloud-based architecture and modular data integration are transforming both sponsor priorities and vendor strategies, paving the way for agile digital transformation as organizations modernize legacy trial systems.
  • The transition toward decentralized and patient-focused studies requires high interoperability between technology and service layers, improving both data acquisition and participant engagement throughout the trial lifecycle.
  • Strategic alliances and holistic service-software bundles can streamline compliance and reduce administrative burden, allowing sponsors to manage global portfolios more efficiently amid shifting regulatory expectations.
  • Consistent investment in consulting, implementation, and ongoing support reduces operational risk, ensuring technology adoption is both effective and sustainable over the long term.
  • Adapting compliance strategies with regional data residency and layered governance enables global scaling while preserving responsiveness to local regulatory nuances.
  • Leaders leveraging scenario-based vendor evaluation and robust change management achieve higher trial consistency and resilience to external disruption.

Tariff Impact: 2025 Policy Shifts and Supply Chain Considerations

Recent adjustments in United States tariff policy for 2025 are increasing the complexity of global procurement for eClinical technology. Elevated duties and heightened cross-border service concerns require organizations to sharpen their approaches to supplier localization, risk management, and supply chain diversification. Many sponsors are shifting to regional cloud hosting and renegotiating contracts to contain exposure to sudden cost surges. While such approaches can increase integration overhead, adopting modular architectures and layered procurement strategies is essential for continuity and adaptability during rapid policy changes. Senior leaders recognize that flexible delivery models and careful regional planning are now crucial for maintaining uninterrupted clinical operations.

Methodology & Data Sources

This report synthesizes direct interviews with professionals in clinical operations, technology strategy, and system implementation, complemented by vendor briefings to validate the capabilities of leading product and service offerings. Objective secondary data from regulatory publications and sector-specific commentary underpins all findings, ensuring segment-level relevance and verification.

Why This Report Matters

  • Navigate the complexities of implementing interoperable, cloud-enabled eClinical solutions while addressing integration and compliance risks effectively.
  • Apply actionable strategies to synchronize investments across teams, processes, and technology, thereby supporting resilient and timely clinical trial execution.
  • Utilize expert insights to refine procurement, vendor selection, and governance frameworks, equipping organizations to respond nimbly to regulatory adjustments and supply chain evolution.

Conclusion

For senior executives guiding the future of eClinical technology, emphasizing modular system design, strategic partner collaboration, and disciplined governance will drive agility and competitive strength in clinical operations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. eClinical Solutions Market, by Component
8.1. Services
8.1.1. Consulting
8.1.2. Implementation
8.1.3. Support And Maintenance
8.2. Software
8.2.1. Ctms
8.2.2. Ecoa
8.2.3. Edc
8.2.4. Etmf
9. eClinical Solutions Market, by Trial Phase
9.1. Phase I
9.2. Phase Ii
9.3. Phase Iii
9.4. Phase Iv
10. eClinical Solutions Market, by Therapeutic Area
10.1. Cardiology
10.2. Neurology
10.3. Oncology
11. eClinical Solutions Market, by Deployment
11.1. Cloud
11.1.1. Hybrid Cloud
11.1.2. Private Cloud
11.1.3. Public Cloud
11.2. On Premise
12. eClinical Solutions Market, by End User
12.1. Academic Research Institutes
12.2. Contract Research Organizations
12.3. Hospitals And Clinics
12.4. Pharma And Biotech
13. eClinical Solutions Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. eClinical Solutions Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. eClinical Solutions Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States eClinical Solutions Market
17. China eClinical Solutions Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. ArisGlobal, Inc.
18.6. Castor EDC B.V.
18.7. Clario, Inc.
18.8. ClinCapture, Inc.
18.9. Datatrak International Ltd.
18.10. eClinical Solutions, Inc.
18.11. IQVIA Inc.
18.12. Labcorp Drug Development, LLC
18.13. Medable, Inc.
18.14. Medidata Solutions, Inc.
18.15. Medrio, Inc.
18.16. OmniComm Systems, Inc.
18.17. OpenClinica, LLC
18.18. Oracle Corporation
18.19. Parexel International Corporation
18.20. REDCap Cloud, Inc.
18.21. Saama Technologies, Inc.
18.22. Signant Health, Inc.
18.23. Veeva Systems Inc.
18.24. Viedoc AB
List of Figures
FIGURE 1. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ECLINICAL SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CTMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CTMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CTMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ECOA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ECOA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ECOA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY EDC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY EDC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY EDC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ETMF, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ETMF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ETMF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE IV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHARMA AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHARMA AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHARMA AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 125. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 130. EUROPE ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 143. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 148. AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 161. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 162. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 163. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 166. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 167. ASEAN ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 170. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 171. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 172. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 173. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 174. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 175. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 176. GCC ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 188. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 189. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 190. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 191. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 192. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 193. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 194. BRICS ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 197. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 198. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 199. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 200. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 201. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 202. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 203. G7 ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 206. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 207. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 208. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 209. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 210. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 211. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 212. NATO ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. CHINA ECLINICAL SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 225. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 226. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 227. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
TABLE 228. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 229. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 230. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 231. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this eClinical Solutions market report include:
  • ArisGlobal, Inc.
  • Castor EDC B.V.
  • Clario, Inc.
  • ClinCapture, Inc.
  • Datatrak International Ltd.
  • eClinical Solutions, Inc.
  • IQVIA Inc.
  • Labcorp Drug Development, LLC
  • Medable, Inc.
  • Medidata Solutions, Inc.
  • Medrio, Inc.
  • OmniComm Systems, Inc.
  • OpenClinica, LLC
  • Oracle Corporation
  • Parexel International Corporation
  • REDCap Cloud, Inc.
  • Saama Technologies, Inc.
  • Signant Health, Inc.
  • Veeva Systems Inc.
  • Viedoc AB

Table Information